retatrutide uses Retatrutide: Fat Loss, Liver Health & Muscle Care A review of an investigational

This definition does not imply medical or scientific superiority or guaranteed results

These approaches give you and your doctor a chance to monitor how your hunger, weight and metabolic markers respond

Functional Performance Profile Key Benefits Triple Agonist: GLP-1, GIP & Glucagon Advanced Weight Loss Muscle Preservation Metabolic Optimisation Improved Energy & Focus Product Specifications Purity: 99.8% Form: Lyophilized peptide Storage: 2-9C Refrigerated Research Information Type: Triple receptor agonist Pathways: GLP-1 / GIP / Glucagon Focus: Metabolic regulation Scientific Information Research Reference Parameters Laboratory Use Only Initial phase: 2-4 mg once weekly Standard research range: 5-8 mg once weekly Advanced research range: 8-12 mg once weekly Research cycles typically extend 8-16 weeks Mechanism of Action Retatrutide functions as a triple agonist: GIP activation enhances insulin secretion and fat metabolism

As monotherapy, cagrilintide produced 11.8% weight loss in the Phase 3 REDEFINE 1 trial at 68 weeks with the 2.4 mg dose

Retatrutide Dosing Current retatrutide dosing follows a gradual dose-escalation approach to improve tolerability and reduce gastrointestinal side effects

Licensed UK weight management medicines include semaglutide 2.4 mg (Wegovy) under NICE TA875